In general, the prognosis between the mRNA and protein expression levels of members of the PI3K/AKT/mTOR signaling pathway was consistent, with the majority being recognized as favorable prognostic factors in patients with ccRCC. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.